Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28,831 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pegylated liposomal doxorubicin (Duomeisu®) monotherapy in patients with HER2-negative metastatic breast cancer heavily pretreated with anthracycline and taxanes: a single-arm, phase II study.
Jiang H, Li H, Song G, Di L, Shao B, Yan Y, Liu X, Chen Y, Zhang R, Ran R, Liu Y, Gui X, Wang N, Wang H. Jiang H, et al. Breast Cancer Res Treat. 2023 May;199(1):67-79. doi: 10.1007/s10549-023-06894-3. Epub 2023 Mar 6. Breast Cancer Res Treat. 2023. PMID: 36877215 Free PMC article. Clinical Trial.
Specific genetic polymorphisms of IL10-592 AA and IL10-819 TT genotypes lead to the key role for inducing docetaxel-induced liver injury in breast cancer patients.
Liang X, Zhang J, Zhu Y, Lu Y, Zhou X, Wang Z, Yu J, Yan Y, Di L, Che L, Jiang H, Shao B, Wang X, Yang H, Lyerly HK, Ren J. Liang X, et al. Among authors: jiang h. Clin Transl Oncol. 2013 Apr;15(4):331-4. doi: 10.1007/s12094-012-0936-6. Epub 2012 Nov 10. Clin Transl Oncol. 2013. PMID: 23143946
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences.
Ren J, Di L, Song G, Yu J, Jia J, Zhu Y, Yan Y, Jiang H, Liang X, Che L, Zhang J, Wan F, Wang X, Zhou X, Lyerly HK. Ren J, et al. Among authors: jiang h. Clin Transl Oncol. 2013 Oct;15(10):780-8. doi: 10.1007/s12094-013-1001-9. Epub 2013 Jan 29. Clin Transl Oncol. 2013. PMID: 23359185 Clinical Trial.
28,831 results
You have reached the last available page of results. Please see the User Guide for more information.